Notice of Intent to Publish a Funding Opportunity Announcement for NCI Pathway to Independence Award (K99/R00 – Independent Clinical Trial Optional)
Notice Number:
NOT-CA-24-077

Key Dates

Release Date:
July 03, 2024
Estimated Publication Date of Notice of Funding Opportunity :
November 01, 2024
First Estimated Application Due Date:
February 14, 2025
Earliest Estimated Award Date:
January 02, 2026
Earliest Estimated Start Date:
January 02, 2026
Related Announcements

None

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) intends to issue a Notice of Funding Opportunity (NOFO), the NCI  Pathway to Independence Award (K99/R00 - Independent Clinical Trial optional) that makes significant changes to the NIH Pathway to Independence Award (Parent K99/R00), including expanding the K99 eligibility window from 4 to 6 years of postdoctoral research training experience. 

The primary purpose of the NCI Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of talented and creative NCI-supported independent investigators. The NOFO is designed to facilitate the transition of talented postdoctoral researchers who have up to 6 years of post-graduation research training experience from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees to launch competitive, independent cancer-research careers in the scientific areas relevant to the mission of NCI.

This Notice is being provided to allow sufficient time for applicants to develop strong applications.
 

Research Initiative Details

The program is designed to facilitate the transition of talented postdoctoral researchers who have up to 6 years of postgraduation research experience to independent tenure-track (or equivalent) faculty positions. In addition, the NCI K99/R00 award is intended to foster the development of an independent research program that will be competitive for subsequent independent funding and that will help advance the mission of NCI.

Postdoctoral scientists conducting research in all areas of cancer research are encouraged to apply for this career development grant program.
 

Funding Information

Estimated Total Funding

TBD

Expected Number of Awards
TBD
Estimated Award Ceiling

TBD

Primary Assistance Listing Number(s)

93.398

Anticipated Eligible Organizations
Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
Independent school districts
Public housing authorities/Indian housing authorities
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
U.S. Territory or Possession
Indian/Native American Tribal Government (Other than Federally Recognized)
Regional Organization
Eligible Agencies of the Federal Government

The sponsoring institution may be private (profit or nonprofit) or public, including the NIH Intramural Programs and other Federal laboratories.

 The applicant institution will be the mentored phase (K99) institution. All institution/organization types listed above are eligible for both the mentored (K99) and independent (R00) phase, with the following exceptions: (1) Eligible agencies of the Federal government, such as the NIH intramural program, are eligible only for the mentored phase; and (2) Eligibility of organizations, other than institutions of higher education, for the R00 phase depends on the nature of the appointment, and the ability of the PD/PI to conduct independent research and apply for NIH research (R01 or R01-equivalent) grants.

Applications are not being solicited at this time. 

Inquiries

Please direct all inquiries to:


Michael Schmidt, Ph.D.
National Cancer Institute (NCI)
Center for Cancer Training
Telephone: 240-460-6896
Email: [email protected]